BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$255B |
| 2 |
Thermo Fisher Scientific
TMO
|
+$458M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$288M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$199M |
| 5 |
Advanced Micro Devices
AMD
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$622M |
| 2 |
Microsoft
MSFT
|
+$543M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$533M |
| 4 |
Amazon
AMZN
|
+$353M |
| 5 |
Diageo
DEO
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.41% |
| 2 | Financials | 6.24% |
| 3 | Healthcare | 5.83% |
| 4 | Consumer Discretionary | 5.56% |
| 5 | Industrials | 3.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Digital Turbine
APPS
$1.53B
| $3.69M | 0.01% |
256,163
+58,594
| +30% | +$1.12M |
|
|
EBAC
1327
DELISTED
European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC
| $3.69M | 0.01% |
+496,000
| New | +$4.89M |
|
1328
Five Below
FIVE
$13.4B
| $3.69M | 0.01% |
26,806
+23,139
| +631% | +$3.04M |
|
1329
BP
BP
$110B
| $3.69M | 0.01% |
129,239
+64,229
| +99% | +$1.91M |
|
1330
First Citizens BancShares
FCNCA
$25.6B
| $3.69M | 0.01% |
4,625
-747
| -14% | -$584K |
|
1331
Golar LNG
GLNG
$5.21B
| $3.68M | 0.01% |
147,723
+94,295
| +176% | +$2.35M |
|
1332
SAP
SAP
$242B
| $3.68M | 0.01% |
45,276
-28,856
| -39% | -$2.55M |
|
|
FOLD
1333
DELISTED
Amicus Therapeutics
FOLD
| $3.67M | 0.01% |
351,746
+8,094
| +2% | +$90.2K |
|
|
JNPR
1334
PUT
DELISTED
Juniper Networks
JNPR
| $3.66M | 0.01% |
1,401
| – | – |
|
1335
PUT
Medtronic
MDT
$116B
| $3.66M | 0.01% |
453
+10
| +2% | +$899 |
|
1336
State Street SPDR S&P Insurance ETF
KIE
$681M
| $3.65M | 0.01% |
100,900
-203,900
| -67% | -$7.78M |
|
|
CPRX
1337
DELISTED
Catalyst Pharmaceutical
CPRX
| $3.62M | 0.01% |
282,017
+251,191
| +815% | +$2.98M |
|
|
1338
CALL
State Street SPDR S&P Insurance ETF
KIE
$681M
| $3.62M | 0.01% |
+1,000
| New | +$38.2K |
|
1339
United Therapeutics
UTHR
$21.5B
| $3.62M | 0.01% |
17,266
+1,116
| +7% | +$249K |
|
1340
AutoNation
AN
$6.89B
| $3.61M | 0.01% |
35,472
-14,978
| -30% | -$1.76M |
|
1341
Ormat Technologies
ORA
$6.98B
| $3.61M | 0.01% |
41,883
+23,590
| +129% | +$2.1M |
|
1342
PUT
Accenture
ACN
$109B
| $3.6M | 0.01% |
140
-20
| -13% | -$5.78K |
|
1343
Eagle Materials
EXP
$6.41B
| $3.6M | 0.01% |
33,582
+7,120
| +27% | +$853K |
|
1344
Coupang
CPNG
$29.3B
| $3.59M | 0.01% |
+215,654
| New | +$3.73M |
|
1345
Riot Platforms
RIOT
$7.21B
| $3.58M | 0.01% |
511,281
+483,892
| +1,767% | +$3.41M |
|
1346
Marten Transport
MRTN
$1.24B
| $3.58M | 0.01% |
187,039
+7,524
| +4% | +$151K |
|
1347
Arcus Biosciences
RCUS
$3.67B
| $3.58M | 0.01% |
136,957
+73,204
| +115% | +$1.94M |
|
1348
ASE Group
ASX
$103B
| $3.58M | 0.01% |
717,697
-679,357
| -49% | -$3.83M |
|
1349
CALL
Western Digital
WDC
$168B
| $3.58M | 0.01% |
1,455
| – | – |
|
1350
iShares MSCI Canada ETF
EWC
$6.55B
| $3.56M | 0.01% |
115,841
| – | – |
|
Similar funds
BNP Paribas Financial Markets's Q3 2022 Portfolio in Review
As of Q3 2022, BNP Paribas Financial Markets held 5,152 positions worth $62.5B, down 2.4% from $64.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
BNP Paribas Financial Markets deployed $254B of net new capital in Q3 2022, opening 1,204 new positions and adding to 1,887 existing holdings. Its largest new stake was Marvell Technology: 910,010 shares worth $39M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $622M trimmed.
- BNP Paribas Financial Markets's largest Q3 2022 buy was Marvell Technology: 910,010 shares worth $39M.
- BNP Paribas Financial Markets added most to Berkshire Hathaway Class A in Q3 2022, an estimated $255B increase.
- BNP Paribas Financial Markets's biggest Q3 2022 reduction was Apple, cutting an estimated $622M.
- BNP Paribas Financial Markets fully exited Alphabet (Google) Class A in Q3 2022, selling an estimated $533M.
- BNP Paribas Financial Markets's ten largest holdings make up 12% of its $62.5B portfolio in Q3 2022.
- BNP Paribas Financial Markets opened 1,204 new positions and closed 420 in Q3 2022.
- BNP Paribas Financial Markets's portfolio value fell 2.4% quarter-over-quarter to $62.5B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2022, filed 15 Nov 2022.